News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Coave Therapeutics to Present at Cell and Gene Meeting on the Mesa
Monday, September 26, 2022Coave Therapeutics gene therapies CNS diseases eye diseases company overview Cell and Gene Meeting on the Mesa Carlsbad California
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
Thursday, September 22, 2022The FDA has accepted ImmunityBio Incs Biologics License Application BLA for review The BLA focuses on their antibody cytokine fusion protein as a potential treatment for BCGunresponsive nonmuscleinvasive bladder cancer carcinoma in situ CIS ImmunityB...
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
Wednesday, September 21, 2022CytoReason today announced an extension of its multiyear partnership with Pfizer to use CytoReasons artificial intelligence technology for Pfizers drug development programs Under the terms of the agreement Pfizer will make a M equity investment have...
Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19
Wednesday, September 21, 2022AstraZenecas Evusheld tixagevimab and cilgavimab formerly AZD a longacting antibody combination has been approved in the European Union EU for the treatment of adults and adolescents aged years and older weighing at least kg with COVID who do not r...
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
Tuesday, September 20, 2022GENFIT a latestage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases today announced it has entered into an exclusivity agreement with a view to acquire all the share capital and voting rights o...
Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS)
Thursday, September 15, 2022Mallinckrodt plc a global specialty pharmaceutical company today announced that the US Food and Drug Administration FDA approved Terlivaz terlipressin for injection Terlivaz is the first and only FDAapproved product indicated to improve kidney functi...
QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug
Thursday, September 15, 2022QIAGEN and Neuron Inc an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases today announced the signing of an agreement to develop a companion diagnostic for Neu...
Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce’s PF614-MPAR
Wednesday, September 14, 2022Ensysce Biosciences Inc a clinicalstage biotech company applying transformative chemistry to improve prescription drug safety and Quotient Sciences a drug development and manufacturing accelerator has announced a partnership to support the developmen...
MD Anderson and Radiopharm Theranostics Launch Joint Venture to Develop Novel Radiopharmaceuticals
Wednesday, September 14, 2022The University of Texas MD Anderson Cancer Center and Radiopharm Theranostics Limited announced the launch of Radiopharm Ventures LLC a joint venture company created to develop novel radiopharmaceutical therapeutic products for cancer Radiopharm Vent...
MagBio Receives 510(k) Clearance and CE Mark for MagXtract Collection Tube For COVID-19 Testing
Tuesday, September 13, 2022MagBio Genomics Inc a global company focused on magnetic beadbased products for molecular diagnostics and liquid biopsy genomic research announced US Food and Drug Administration FDA k clearance CE Mark approval and global launch of its MagXtract Col...
